Publication: Dramatic reduction of ventricular tachycardia burden after dronedarone plus mexiletine treatment in a patient refractory to hybrid ablation.
dc.contributor.author | Frutos-López, Manuel | |
dc.contributor.author | Pedrote, Alonso | |
dc.contributor.author | Acosta-Martínez, Juan | |
dc.contributor.author | Arana-Rueda, Eduardo | |
dc.date.accessioned | 2023-02-08T14:47:17Z | |
dc.date.available | 2023-02-08T14:47:17Z | |
dc.date.issued | 2020-04-23 | |
dc.description.abstract | Antiarrhythmic drugs are often the last resort for recurrent ventricular tachycardia refractory to catheter ablation in implantable cardioverter-defibrillator carriers. Amiodarone, alone or combined with mexiletine, is usually but not always highly effective, and its use is usually limited by systemic adverse effects. We present the case of a 62 years old man with recurrent ICD shocks due to a VT refractory to an endo-epicardial hybrid ablation. Starting of dronedarone plus mexiletine combination showed an excellent result. | |
dc.identifier.doi | 10.1016/j.repc.2017.11.018 | |
dc.identifier.essn | 2174-2049 | |
dc.identifier.pmid | 32336522 | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.repc.2017.11.018 | |
dc.identifier.uri | http://hdl.handle.net/10668/15435 | |
dc.issue.number | 3 | |
dc.journal.title | Revista portuguesa de cardiologia | |
dc.journal.titleabbreviation | Rev Port Cardiol (Engl Ed) | |
dc.language.iso | en | |
dc.language.iso | pt | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.page.number | 171-173 | |
dc.pubmedtype | Case Reports | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Ablação por cateter | |
dc.subject | Antiarrhythmic drugs | |
dc.subject | Arritmias ventriculares | |
dc.subject | Catheter ablation | |
dc.subject | Dronedarona | |
dc.subject | Dronedarone | |
dc.subject | Fármacos anti-arrítmicos | |
dc.subject | Mexiletina | |
dc.subject | Mexiletine | |
dc.subject | Ventricular arrhythmias | |
dc.subject.mesh | Amiodarone | |
dc.subject.mesh | Anti-Arrhythmia Agents | |
dc.subject.mesh | Catheter Ablation | |
dc.subject.mesh | Defibrillators, Implantable | |
dc.subject.mesh | Dronedarone | |
dc.subject.mesh | Drug Therapy, Combination | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Male | |
dc.subject.mesh | Mexiletine | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Tachycardia, Ventricular | |
dc.subject.mesh | Treatment Outcome | |
dc.title | Dramatic reduction of ventricular tachycardia burden after dronedarone plus mexiletine treatment in a patient refractory to hybrid ablation. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 39 | |
dspace.entity.type | Publication |